Anti-Caveolin-2 antibody [EPR2220] - Caveolae Marker
- RabMAb
- Recombinant
- Lab Essentials
- What is this?
Be the first to review this product! Submit a review
|
(5 Publications)
Rabbit Recombinant Monoclonal Caveolin-2 antibody. Caveola marker. Suitable for WB, ICC/IF, Flow Cyt (Intra), IHC-P and reacts with Human samples. Cited in 5 publications.
View Alternative Names
Caveolin-2, CAV2
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Caveolin-2 antibody [EPR2220] - Caveolae Marker (AB79397)
ab79397 at 1/100 dilution staining Caveolin-2 in HeLa cells by Immunofluorescence.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Caveolin-2 antibody [EPR2220] - Caveolae Marker (AB79397)
ab79397 at 1/100 dilution staining Caveolin-2 in human uterus by Immunohistochemistry using paraffin-embedded tissue. Note staining of endothelial cells and smooth muscles.
Perform heat mediated antigen retrieval with EDTA buffer pH 9 before commencing with IHC staining protocol.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-Caveolin-2 antibody [EPR2220] - Caveolae Marker (AB79397)
Intracellular Flow Cytometry analysis of HeLa (human cervix adenocarcinoma) cells labeling Caveolin-2 (red) with ab79397 at a 1/2000 dilution. Cells were fixed with 80% methanol and permeabilized with 0.1% Tween-20. A goat anti-rabbit IgG (Alexa Fluorr® 488) (ab150077) was used as the secondary antibody at a 1/2000 dilution. Black - Rabbit monoclonal IgG (ab172730). Blue (unlabeled control) - Cells without incubation with the primary and secondary antibodies.
- WB
Unknown
Western blot - Anti-Caveolin-2 antibody [EPR2220] - Caveolae Marker (AB79397)
All lanes:
Western blot - Anti-Caveolin-2 antibody [EPR2220] - Caveolae Marker (ab79397) at 1/5000 dilution
All lanes:
HeLa cell lysate at 10 µg
Secondary
All lanes:
Goat anti-rabbit HRP conjugated at 1/2000 dilution
Predicted band size: 18 kDa
Observed band size: 20 kDa
false
Related conjugates and formulations (1)
-
Anti-Caveolin-2 antibody [EPR2220] - BSA and Azide free
Reactivity data
Product details
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Caveolin-2 participates in modulating cellular functions such as signal transduction cholesterol homeostasis and endocytosis. As part of the caveolae complex it cooperates with caveolin-1 to regulate lipid raft domains influencing the movement and function of molecules within the cell. The presence of caveolin-2 helps maintain the caveolae structure and is involved in cellular responses to mechanical stress.
Pathways
Caveolin-2 is implicated in the regulation of insulin signaling and the Ras-MAPK signaling pathway. In the insulin signaling pathway it forms complexes with caveolin-1 and other proteins like IRS-1 affecting glucose uptake in cells. In the Ras-MAPK pathway caveolin-2 interacts with signaling molecules associated with the pathway modulating cell proliferation and survival.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (5)
Recent publications for all applications. Explore the full list and refine your search
Journal of Cancer 14:2001-2014 PubMed37497407
2023
Applications
Unspecified application
Species
Unspecified reactive species
NAR cancer 4:zcac036 PubMed36381271
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in oncology 11:703501 PubMed34513683
2021
Applications
Unspecified application
Species
Unspecified reactive species
Scientific data 8:147 PubMed34050191
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cell and tissue research 374:121-136 PubMed29752569
2018
Applications
Unspecified application
Species
Human
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com